课题基金 / 基金详情

项目摘要

项目成果

Carlos L Arteaga的其他基金

相似基金

相关文献

中文摘要
翻译
行政和外展核心通过管理孢子来支持孢子项目和调查人员 资源、质量控制以及沟通和推广,包括促进孢子之间的相互作用 组件和合作者,其他孢子,患者和倡导者社区,以及NCI。这 管理和支持是通过一系列监督委员会完成的,并组织 孢子调查员、机构代表和外部人员的行政和科学会议 顾问。核心的具体职能包括: ·行政管理和协调所有与孢子有关的研究 ·监测和管理财政资源 ·创建和准备文件和报告,以确保遵守联邦法规和 报告要求 ·管理发展研究(试点项目)和职业发展方案 ·组织所有与乳腺癌孢子活动有关的会议、研讨会和旅行 ·作为所有以乳腺癌为重点的VICC筹款活动的联络点 ·支持和协调所有内部和外部协作 ·作为生物技术和制药公司的主要联络点 医学博士卡洛斯·L·阿泰加和MSSW的简·肯尼迪将担任核心的联席董事。Arteaga报道 直接提交给VICC主任Jennifer Pietenpol博士,并得到副主任的投入和协助 (丹尼尔·比彻姆,医学博士)和基础科学(斯科特·希伯特博士)和癌症副主任 流行病学、预防与控制(威廉·布洛特博士)。Arteaga为Pietenpoll博士提供关于 乳腺癌研究中VICC资源的规划方向和分配。自2006年以来,简女士 肯尼迪曾在VICC患者和社区教育办公室担任患者倡导经理 (OPACE)。肯尼迪女士的职责包括招募、培训和协调幸存者和照顾者 帮助和支持VICC的研究倡导计划,包括乳孢子。
英文摘要
The Administration & Outreach Core supports SPORE projects and investigators by managing SPORE resources, quality control, and communication and outreach, including fostering interaction among SPORE components and collaborators, other SPORES, the patient and advocate community, and the NCI. This management and support is accomplished through a series of oversight committees and organized administrative and scientific meetings of SPORE investigators, institutional representatives and external advisors. Specific functions of the Core include: • To administratively manage and coordinate all SPORE-related research • To monitor and manage financial resources • To create and prepare documents and reports to ensure compliance with federal regulations and reporting requirements • To administer the Developmental Research (pilot project) and Career Development Programs • To organize all meetings, seminars, and travel related to Breast Cancer SPORE activities • To serve as a point of contact to all VICC fundraising activities focused in breast cancer • To support and coordinate all internal and external collaborations • To serve as a main point of contact to biotechnology and pharmaceutical companies Carlos L. Arteaga, MD, and Jane Kennedy, MSSW, will serve as co-Directors of the Core. Arteaga reports directly to Jennifer Pietenpol, PhD, Director of VICC, and has input and assistance from the Deputy Director (Daniel Beauchamp, MD) and the Associate Directors for Basic Science (Scott Hiebert, PhD) and Cancer Epidemiology, Prevention & Control (William Blot, PhD). Arteaga provides advice to Dr. Pietenpol on programmatic directions and allocation of VICC resources for research in breast cancer. Since 2006, Ms. Jane Kennedy has served as Manager of Patient Advocacy in the VICC Office of Patient & Community Education (OPACE). Ms. Kennedy's role includes recruiting, training and coordinating the survivors and caregivers who contribute to and support the Research Advocacy Program of VICC, including the Breast SPORE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    9759820
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10214565
  • 项目类别:
  • 资助金额:
    $36.83万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10458531
  • 项目类别:
  • 资助金额:
    $36.09万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
海外基金